Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE236408 | GEO | 2023/07/04

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Molecular fingerprints for bone marrow cells, pediatric acute lymphoblastic leukemia

Project description:The overall goal of this study was to characterize bone marrow cells based on their transcriptome, surface protein expression and BCR- and TCR VDJ-profile for accurate identification of clinically relevant cell states. This submission includes pediatric B-cell acute lymphoblastic leukemia samples. This project has received funding from the European Union Horizon 2020 research and innovation programme under grant agreement No 824110 (EASI-Genomics)

2023-05-03 | GSE230295 | GEO

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [scRNA-seq]

Project description:The overall goal of this study was to characterize bone marrow cells based on their transcriptome, surface protein expression and BCR-VDJ-profile for accurate identification of clinically relevant cell states. This submission includes B-cell acute lymphoblastic (pre-)leukemia samples from mice. This project has received funding from ERA perMed JTC2018 under the title „Genomics-based tools for personalized treatment to reduce chemotherapy burden in paediatric cancer” (Acronym “GEPARD”)

2023-07-04 | GSE236407 | GEO

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [bulk RNA-seq]

Project description:The overall goal of this study was to characterize bone marrow cells based on their transcriptome. This submission includes preleukemic samples (B-cell acute lymphoblastic leukemia) from 6 mice. This project has received funding from ERA perMed JTC2018 under the title „Genomics-based tools for personalized treatment to reduce chemotherapy burden in paediatric cancer” (Acronym “GEPARD”)

2023-07-04 | GSE236406 | GEO

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia

Project description:Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia

| PRJNA990760 | ENA

Molecular fingerprints for bone marrow cells, pediatric acute lymphoblastic leukemia

Project description:Molecular fingerprints for bone marrow cells, pediatric acute lymphoblastic leukemia

| PRJNA958206 | ENA

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [scRNA-seq]

Project description:Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [scRNA-seq]

| PRJNA990769 | ENA

The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-08-24 | GSE182174 | GEO

Acute lymphoblastic leukemia

Project description:This SuperSeries is composed of the SubSeries listed below.

2010-09-10 | GSE24001 | GEO

Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.

Project description:In acute lymphoblastic leukemia (ALL) the bone marrow microenvironment provides growth and survival signals that may confer resistance to chemotherapy. Granulocyte colony-stimulating factor (G-CSF) potently inhibits lymphopoiesis by targeting stromal cells that comprise the lymphoid niche in the bone marrow. To determine whether lymphoid niche disruption by G-CSF sensitizes ALL cells to chemotherapy, we conducted a pilot study of G-CSF in combination with chemotherapy in patients with relapsed or refractory ALL. Thirteen patients were treated on study; three patients achieved a complete remission (CR/CRi) for an overall response rate of 23%. In the healthy volunteers, G-CSF treatment disrupted the lymphoid niche, as evidenced by reduced expression of CXCL12, interleukin-7, and osteocalcin. However, in most patients with relapsed/refractory ALL expression of these genes was markedly suppressed at baseline. Thus, although G-CSF treatment was associated with ALL cell mobilization into the blood, and increased apoptosis of bone marrow resident ALL cells, alterations in the bone marrow microenvironment were modest and highly variable. These data suggest that disruption of lymphoid niches by G-CSF to sensitize ALL cells to chemotherapy may be best accomplished in the consolidation where the bone marrow microenvironment is more likely to be normal.

| S-EPMC4661095 | biostudies-literature

Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [bulk RNA-seq]

Project description:Molecular fingerprints for bone marrow cells, acute lymphoblastic leukemia [bulk RNA-seq]

| PRJNA990764 | ENA